Search research articles
Contact Us
Filters
Showing results (151-160 of 631) with videos related to
Page
of 64
Sort By:
Seminars in Ophthalmology
|
June 28, 2008
Who (what) pays toll for the development of herpetic stromal keratitis (HSK)
Kozaburo Hayashi, Laura C Hooper, John J Hooks
Journal of Bacteriology
|
September 1, 1991
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus
M Trucksis, J S Wolfson, D C Hooper
Psychopharmacology Bulletin
|
January 1, 1994
Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder
D Bakish, A Ravindran, C Hooper, et al.
Medicine
|
August 26, 1998
Nocardia bacteremia. Report of 4 cases and review of the literature
D P Kontoyiannis, K Ruoff, D C Hooper
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 1, 1992
Synergism of trimethoprim and ciprofloxacin in vitro against clinical bacterial isolates
P Huovinen, J S Wolfson, D C Hooper
Journal of Bacteriology
|
February 15, 2002
NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes
Jian-Lin Yu, Leo Grinius, David C Hooper
International Journal of Antimicrobial Agents
|
January 24, 2018
Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coli
Laura Vinué, David C Hooper, George A Jacoby
Antimicrobial Agents and Chemotherapy
|
June 1, 1994
Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome
E Y Ng, M Trucksis, D C Hooper
Microbiology Spectrum
|
January 14, 2015
Plasmid-mediated quinolone resistance
George A Jacoby, Jacob Strahilevitz, David C Hooper
The Lancet. Infectious Diseases
|
September 30, 2006
The worldwide emergence of plasmid-mediated quinolone resistance
Ari Robicsek, George A Jacoby, David C Hooper
Page
of 64
Search research articles
Search
Showing results (151-160 of 631) with videos related to
Sort By:
Page
of 64
Seminars in Ophthalmology
|
June 28, 2008
Who (what) pays toll for the development of herpetic stromal keratitis (HSK)
Kozaburo Hayashi, Laura C Hooper, John J Hooks
Journal of Bacteriology
|
September 1, 1991
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus
M Trucksis, J S Wolfson, D C Hooper
Psychopharmacology Bulletin
|
January 1, 1994
Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder
D Bakish, A Ravindran, C Hooper, et al.
Medicine
|
August 26, 1998
Nocardia bacteremia. Report of 4 cases and review of the literature
D P Kontoyiannis, K Ruoff, D C Hooper
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 1, 1992
Synergism of trimethoprim and ciprofloxacin in vitro against clinical bacterial isolates
P Huovinen, J S Wolfson, D C Hooper
Journal of Bacteriology
|
February 15, 2002
NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes
Jian-Lin Yu, Leo Grinius, David C Hooper
International Journal of Antimicrobial Agents
|
January 24, 2018
Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coli
Laura Vinué, David C Hooper, George A Jacoby
Antimicrobial Agents and Chemotherapy
|
June 1, 1994
Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome
E Y Ng, M Trucksis, D C Hooper
Microbiology Spectrum
|
January 14, 2015
Plasmid-mediated quinolone resistance
George A Jacoby, Jacob Strahilevitz, David C Hooper
The Lancet. Infectious Diseases
|
September 30, 2006
The worldwide emergence of plasmid-mediated quinolone resistance
Ari Robicsek, George A Jacoby, David C Hooper
Page
of 64